![](https://qb3.berkeley.edu/wp-content/uploads/2021/12/Sickle-Cell-750px-1-300x200.jpeg)
$17 million will launch trial of CRISPR cure for sickle cell disease
December 09, 2021
A small clinical trial of a CRISPR cure for sickle cell disease, approved earlier this year by the U.S. Food and Drug Administration, has received $17 million to enroll about nine patients, the first of which may be selected before the end of the year.